70 related articles for article (PubMed ID: 1310513)
1. Dynamic model of differentiation in Ewing's sarcoma cells. Comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters.
Noguera R; Triche TJ; Navarro S; Tsokos M; Llombart-Bosch A
Lab Invest; 1992 Feb; 66(2):143-51. PubMed ID: 1310513
[TBL] [Abstract][Full Text] [Related]
2. Co-regulated expression of dbl and poly(ADP-ribose) polymerase in Ewing's sarcoma cells and dbl-transformed NIH3T3 fibroblasts.
Velasco JA; Ramsamooj P; Thraves PJ; Eva A; Dritschilo A; Notario V
Oncogene; 1995 Jun; 10(11):2253-8. PubMed ID: 7784072
[TBL] [Abstract][Full Text] [Related]
3. dbl oncogene expression in childhood tumors and tumor cell lines.
Navarro S; Pellín A; Noguera R; Díaz MP; Tsokos M; Triche TJ; Llombart-Bosch A
Diagn Mol Pathol; 1993 Sep; 2(3):158-62. PubMed ID: 8287229
[TBL] [Abstract][Full Text] [Related]
4. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
[TBL] [Abstract][Full Text] [Related]
7. Expression of the dbl proto-oncogene in Ewing's sarcomas.
Vecchio G; Cavazzana AO; Triche TJ; Ron D; Reynolds CP; Eva A
Oncogene; 1989 Jul; 4(7):897-900. PubMed ID: 2666909
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
9. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
10. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
[TBL] [Abstract][Full Text] [Related]
11. Different regulation of N- and c-myc expression during phorbol ester-induced maturation of human SH-SY5Y neuroblastoma cells.
Hammerling U; Bjelfman C; Påhlman S
Oncogene; 1987; 2(1):73-7. PubMed ID: 3325885
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
Gewirtz AM; Shen YM
Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
[TBL] [Abstract][Full Text] [Related]
14. N-myc and c-src genes are differentially regulated in PCC7 embryonal carcinoma cells undergoing neuronal differentiation.
Sejersen T; Björklund H; Sümegi J; Ringertz NR
J Cell Physiol; 1986 May; 127(2):274-80. PubMed ID: 3700483
[TBL] [Abstract][Full Text] [Related]
15. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence for a neural origin of Ewing's sarcoma of bone.
Cavazzana AO; Miser JS; Jefferson J; Triche TJ
Am J Pathol; 1987 Jun; 127(3):507-18. PubMed ID: 3035930
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.
Gabor F; Wollmann K; Theyer G; Haberl I; Hamilton G
Anticancer Res; 1994; 14(5A):1943-50. PubMed ID: 7847832
[TBL] [Abstract][Full Text] [Related]
18. Importance of phenotypic and molecular characterization for identification of a neuroepithelioma tumor cell line, NUB-20.
Yeger H; Mor O; Pawlin G; Kaplinsky C; Shiloh Y
Cancer Res; 1990 May; 50(9):2794-802. PubMed ID: 2158399
[TBL] [Abstract][Full Text] [Related]
19. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
20. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
